[REGN] QoQ Quarter Result on 30-Sep-2012 [#Q3]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
24-Oct-2012
Financial Year
2012
Quarter
30-Sep-2012 [#Q3]
Profit Trend
QoQ- 149.49%
YoY- 407.01%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Quarter Result
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
Revenue 457,642 439,664 414,602 427,687 304,399 231,789 122,977 140.33%
PBT 147,692 141,831 134,559 191,468 76,743 11,651 -54,058 -
Tax 60,316 42,957 -335,848 -517 -501 -610 -615 -
NP 87,376 98,874 470,407 191,468 76,743 11,651 -53,443 -
Tax Rate -40.84% -30.29% 249.59% 0.27% 0.65% 5.24% - -
Total Cost 370,266 340,790 -55,805 236,219 227,656 220,138 176,420 63.99%
Ratio Analysis
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
NP Margin 19.09 22.49 113.46 44.77 25.21 5.03 -43.46 -
Per Share
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
EPS 0.89 1.02 4.92 2.02 0.81 0.12 -0.58 -
EPS Diluted 0.79 0.90 4.26 1.72 0.70 0.11 -0.57 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.